SMC accepts breakthrough treatment Entresto™ for use in patients with symptomatic chronic heart failure
Sacubitril/valsartan represents a breakthrough therapeutic option for adult patients with symptomatic chronic heart failure with reduced ejection fraction
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Healthcare professionals Practical therapeutics Cardiovascular medicine Patient care chronic heart failure Latest News sacubitril/valsartan scottish medicines consortium Source Type: news